First-line treatment of advanced ALK-positive non-small-cell lung cancer

Non-small-cell lung cancer (NSCLC) is one of the leading causes of cancer deaths, both within the US and worldwide. There have been major treatment advances in NSCLC over the past decade with the discovery of molecular drivers of NSCLC, which has ushered in an era of personalized medicine. There are...

Descripción completa

Detalles Bibliográficos
Autores principales: Gandhi, Shipra, Chen, Hongbin, Zhao, Yujie, Dy, Grace K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5217519/
https://www.ncbi.nlm.nih.gov/pubmed/28210152
http://dx.doi.org/10.2147/LCTT.S63491

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5217519/
https://www.ncbi.nlm.nih.gov/pubmed/28210152
http://dx.doi.org/10.2147/LCTT.S63491

Ejemplares similares